UBS Group’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.3M | Sell |
171,779
-107,075
| -38% | -$2.53M | ﹤0.01% | 4227 |
|
|
2025
Q4 | $7.34M | Buy |
278,854
+227,013
| +438% | +$4.95M | ﹤0.01% | 3626 |
|
|
2025
Q3 | $885K | Sell |
51,841
-199,669
| -79% | -$2.86M | ﹤0.01% | 5674 |
|
|
2025
Q2 | $3.16M | Buy |
251,510
+37,210
| +17% | +$443K | ﹤0.01% | 4342 |
|
|
2025
Q1 | $2.55M | Buy |
214,300
+47,404
| +28% | +$646K | ﹤0.01% | 4487 |
|
|
2024
Q4 | $2.44M | Buy |
166,896
+31,341
| +23% | +$438K | ﹤0.01% | 4539 |
|
|
2024
Q3 | $1.7M | Buy |
135,555
+9,881
| +8% | +$108K | ﹤0.01% | 4156 |
|
|
2024
Q2 | $1.07M | Buy |
125,674
+58,250
| +86% | +$519K | ﹤0.01% | 4362 |
|
|
2024
Q1 | $709K | Buy |
67,424
+3,010
| +5% | +$33.4K | ﹤0.01% | 4901 |
|
|
2023
Q4 | $669K | Buy |
64,414
+26,594
| +70% | +$212K | ﹤0.01% | 4843 |
|
|
2023
Q3 | $240K | Buy |
37,820
+7,432
| +24% | +$54.9K | ﹤0.01% | 5235 |
|
|
2023
Q2 | $263K | Buy |
30,388
+15,322
| +102% | +$137K | ﹤0.01% | 5296 |
|
|
2023
Q1 | $136K | Buy |
15,066
+15,041
| +60,164% | +$131K | ﹤0.01% | 5673 |
|
|
2022
Q4 | $197 | Hold |
25
| – | – | ﹤0.01% | 10321 |
|
|
2022
Q3 | $0 | Hold |
25
| – | – | ﹤0.01% | 11023 |
|
|
2022
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 11043 |
|
|
2022
Q1 | $0 | Sell |
25
-3,571
| -99% | -$31.8K | ﹤0.01% | 11002 |
|
|
2021
Q4 | $59K | Buy |
3,596
+3,246
| +927% | +$67.7K | ﹤0.01% | 6757 |
|
|
2021
Q3 | $10K | Sell |
350
-430
| -55% | -$14.3K | ﹤0.01% | 8024 |
|
|
2021
Q2 | $28K | Sell |
780
-8,328
| -91% | -$264K | ﹤0.01% | 7011 |
|
|
2021
Q1 | $287K | Buy |
9,108
+1,493
| +20% | +$60.7K | ﹤0.01% | 5235 |
|
|
2020
Q4 | $359K | Buy |
7,615
+1,604
| +27% | +$74.5K | ﹤0.01% | 4850 |
|
|
2020
Q3 | $280K | Buy |
6,011
+1,290
| +27% | +$44.3K | ﹤0.01% | 4592 |
|
|
2020
Q2 | $170K | Sell |
4,721
-2,680
| -36% | -$98.7K | ﹤0.01% | 4916 |
|
|
2020
Q1 | $263K | Sell |
7,401
-22,638
| -75% | -$926K | ﹤0.01% | 4505 |
|
|
2019
Q4 | $1.37M | Sell |
30,039
-12,328
| -29% | -$448K | ﹤0.01% | 3921 |
|
|
2019
Q3 | $1.05M | Buy |
42,367
+40,476
| +2,140% | +$1.01M | ﹤0.01% | 3927 |
|
|
2019
Q2 | $42K | Buy |
1,891
+768
| +68% | +$14.1K | ﹤0.01% | 6074 |
|
|
2019
Q1 | $18K | Buy |
+1,123
| New | +$17.4K | ﹤0.01% | 6400 |
|
|
2018
Q4 | – | Sell |
-2,386
| Closed | -$37K | – | 8353 |
|
|
2018
Q3 | $37K | Buy |
+2,386
| New | +$34.1K | ﹤0.01% | 6401 |
|
|
2018
Q2 | – | Sell |
-440
| Closed | -$5K | – | 8308 |
|
|
2018
Q1 | $5K | Sell |
440
-372
| -46% | -$4.02K | ﹤0.01% | 7251 |
|
|
2017
Q4 | $6K | Buy |
+812
| New | +$6.67K | ﹤0.01% | 7323 |
|
Other funds holding ZYME
EC
RCMNY
BI
PA
VCM
UBS Group's ZYME Position: Q1 2026 in Review
UBS Group reduced its Zymeworks (ZYME) stake by 38% in Q1 2026, selling an estimated $2.53M and leaving 171,779 shares worth $4.3M. The position accounts for ﹤0.01% of the portfolio, ranked #4227.
UBS Group first reported a position in ZYME in Q4 2017 and has held it in 32 quarters since. The position peaked at $7.34M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.
- UBS Group held 171,779 shares of Zymeworks worth $4.3M as of Q1 2026.
- UBS Group sold 107,075 Zymeworks shares in Q1 2026, an estimated $2.53M.
- Zymeworks made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4227 holding.
- UBS Group first reported a position in Zymeworks in Q4 2017 and has held it in 32 quarters since.
- UBS Group's Zymeworks position peaked at $7.34M in Q4 2025.
- 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.